Prognostic value of claudin 18.2 expression in gastric adenocarcinoma

BACKGROUND: Claudin 18.2 (CLDN18.2) is a cell surface protein expressed by gastric cancer cells. The monoclonal antibody zolbetuximab binds CLDN18.2-positive cancer cells and causes cancer cell death. A few studies researched the prognostic effect of CLDN18.2 expression in metastatic gastric adenoca...

Descripción completa

Detalles Bibliográficos
Autores principales: Kayikcioglu, Erkan, Yüceer, Ramazan Oğuz, Cetin, Bulent, Yüceer, Kamuran, Karahan, Nermin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Retrospective Cohort Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994048/
https://www.ncbi.nlm.nih.gov/pubmed/36908327
http://dx.doi.org/10.4251/wjgo.v15.i2.343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994048/
https://www.ncbi.nlm.nih.gov/pubmed/36908327
http://dx.doi.org/10.4251/wjgo.v15.i2.343

Ejemplares similares